Article
Muscular dystrophy breakthrough: FDA approves first-ever gene therapy for rare children's disease
Rating:
0.0
Views:
59
Likes:
1
Library:
1
The FDA has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children 4-5 years of age. Get the details on how Elevidys could help pediatric patients.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value